deltatrials

Austin Health Clinical Trials

Sponsors / Austin Health

ClinicalTrials.gov lists 68 trials for which Austin Health is named as lead sponsor. Of these, 10 are recruiting, 3 are active without new recruitment, and 36 have completed. The registry records 5 terminated or withdrawn trials for Austin Health. The most common reasons cited for termination include efficacy or futility findings. Planned participant enrollment across these trials sums to 23,402. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.

68
Total Trials
10
Recruiting
3
Other Active
36
Completed
5
Terminated / Withdrawn
23,402
Total Enrollment

Termination reasons: Other60% · Efficacy40%

Recent Terminations

  • NCT04297748 Phase PHASE1/PHASE2 Stopped Nov 2022
    Non-Small Cell Lung Cancer
    "Efficacy finding"
  • NCT01266018 Phase PHASE2 Stopped Jan 2014
    Small Cell Lung Cancer
    "Lack of efficacy in Cohort 2; slow enrollment in Cohort 1"
  • NCT00878956 Phase PHASE2 Stopped Jan 2012
    Acute Kidney Injury
  • NCT00672334 Phase PHASE2/PHASE3 Stopped Jan 2012
    Cardiac Surgery
  • NCT00144118 Phase PHASE4 Stopped Aug 2005
    Kidney Failure

Active Trials (3 total)

Top Conditions

Anesthesia (3) Cardiac surgery (3) Acute renal failure (2) Cardiac surgery and cardiopulmonary bypass (2) Critical illness (2) Metastatic colorectal cancer (2) Parkinson's disease (2) Acute kidney dysfunction (1) Acute kidney injury (1) Affective disorders, psychotic (1)

Top Locations

Melbourne, Australia (47) Heidelberg, Australia (20) Ballarat, Australia (5) Box Hill, Australia (4) Perth, Australia (4) Adelaide, Australia (3) Brisbane, Australia (3) Fitzroy, Australia (3) Sydney, Australia (3) Epping, Australia (2)